Skip to main content
. Author manuscript; available in PMC: 2020 May 27.
Published in final edited form as: Toxicol Appl Pharmacol. 2019 May 14;378:114592. doi: 10.1016/j.taap.2019.05.011

Table 3.

Disposition of [14C]DMAE in male and female Wistar Han rats 24 or 72 h following a single gavage or intravenous administration.

% Dose Recovereda
Tissue Male, Gavage
10 mg/kg
Male, Gavage
100 mg/kg
Male, Gavage
500 mg/kg
Male, IV
10 mg/kg
Female, Gavage
500 mg/kg
Male, Gavageb
500 mg/kg
Male, Gavagec
500 mg/kg
Urined 57.0 ± 4.10 58.6 ± 5.10 62.1 ± 1.50 39.2 ± 7.80 63.5 ± 1.80 68.6 ± 2.00 60.4 ± 3.80
Feces 0.206 ± 0.242 0.302 ± 0.061 0.518 ± 0.472 0.330 ± 0.092 0.549 ± 0.147 1.11 ± 1.01 0.538 ± 0.335
VOCs 0.153 ± 0.037 --- 0.198 ± 0.038 0.230 ± 0.029 0.818 ± 0.456 --- 0.220 ± 0.047
CO2 3.67 ± 0.440 4.84 ± 0.700 4.78 ± 0.810 3.52 ± 0.780 6.09 ± 0.810 7.94 ± 1.72e 2.94 ± 0.230
Tissues and GI Tractf 33.9 ± 2.20 30.1 ± 3.80 24.3 ± 2.10 38.5 ± 2.30 27.4 ± 1.40 14.5 ± 1.20 34.1 ± 1.80
Total Recovered 94.9 ± 3.20 93.9 ± 2.90 92.1 ± 1.90 81.8 ± 7.10 98.4 ± 0.800 92.0 ± 2.20 98.3 ± 3.50
a

Mean ± SD, N= 3 animals;

b

72 h, N = 5

c

Sprague Dawley rats

d

Includes urine present in the bladder at study termination

e

Collection was terminated at 39 h

f

Includes contents